GlassScriptPhysician profile
Brian L Hawkins
NPI 1902803646
$3,171.98
in general payments reported to CMS, 2019-2025
23 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $164 · 2021: $542 · 2022: $532 · 2023: $872 · 2024: $431 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.21 |
| Education | $114.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $911.39 | 2021-2025 | Dupixent |
| Genzyme Corporation | $453.22 | 2021-2025 | |
| Optinose US, INC. | $345.45 | 2020-2025 | |
| Glaxosmithkline, LLC. | $341.66 | 2021-2025 | Nucala |
| Kaleo, INC. | $266.15 | 2019-2023 | Auvi-Q |
| Stryker Corporation | $188.70 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $68.86 | 2024-2025 | Voquezna |
| Inspire Medical Systems, INC. | $68.30 | 2023 | Inspire |
| Kerecis Limited | $64.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $60.18 | 2021 | |
| Intersect Ent, INC. | $51.59 | 2021 | |
| Pfizer INC. | $50.87 | 2022-2023 | |
| Amgen INC. | $48.22 | 2025 | |
| Smith+Nephew, INC. | $38.36 | 2023 | Tula |
| Phadia US INC. | $36.63 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35.33 | 2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $26.57 | 2025 | Neffy |
| Cochlear Americas | $22.40 | 2019 | |
| Alk-Abello, INC | $21.91 | 2021 | |
| Uswm, LLC | $20.68 | 2021 | |
| Acclarent, INC | $18.26 | 2019 | |
| Merck Sharp & Dohme LLC | $17.24 | 2023 | |
| Checkpoint Surgical, INC | $15.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.